Novel endotypes in heart failure: effects on guideline-directed medical therapy.

Tromp, J; Ouwerkerk, W; Demissei, B G; Anker, S D; Cleland, J G; Dickstein, K; Filippatos, G; van der Harst, P; Hillege, H L; Lang, C C; Metra, M; Ng, L L; Ponikowski, P; Samani, N J; van Veldhuisen, D J; Zannad, F; Zwinderman, A H; Voors, A A; van der Meer, P

Tromp, J; Ouwerkerk, W; Demissei, B G; Anker, S D; Cleland, J G; Dickstein, K; Filippatos, G; van der Harst, P; Hillege, H L; Lang, C C; Metra, M; Ng, L L; Ponikowski, P; Samani, N J; van Veldhuisen, D J; Zannad, F; Zwinderman, A H; Voors, A A; van der Meer, P.

Affiliation

Tromp J; Department of Cardiology, University of Groningen, Hanzeplein 1, GZ, Groningen, the Netherlands.
Ouwerkerk W; National Heart Centre Singapore, 5 Hospital Drive, Singapore.
Demissei BG; Duke-NUS Medical School, 8 College Road, Singapore.
Anker SD; National Heart Centre Singapore, 5 Hospital Drive, Singapore.
Cleland JG; Department of Epidemiology, Biostatistics & Bioinformatics, Academic Medical Center, Amsterdam, Meibergdreef 9, AZ, The Netherlands.
Dickstein K; Department of Cardiology, University of Groningen, Hanzeplein 1, GZ, Groningen, the Netherlands.
Filippatos G; Division of Cardiology and Metabolism-Heart Failure, Cachexia & Sarcopenia, Department of Cardiology (CVK); Berlin-Brandenburg Center for Regenerative Therapies (BCRT), at Charité University Medicine, Charitépl. 1 Berlin, Germany.
van der Harst P; Department of Cardiology and Pneumology, University Medicine Göttingen (UMG), DZHK (German Center for Cardiovascular Research), Robert-Koch-Straße 40, Göttingen, Germany.
Hillege HL; National Heart & Lung Institute, Royal Brompton & Harefield Hospitals, Imperial College, Sydney St, Chelsea, London, UK.
Lang CC; Robertson Institute of Biostatistics and Clinical Trials Unit, University of Glasgow, University Avenue, Glasgow, UK.
Metra M; University of Bergen, Stavanger University Hospital, Gerd-Ragna Bloch Thorsens gate 8, Stavanger, Norway.
Ng LL; School of Medicine, Department of Cardiology, Heart Failure Unit, Athens University Hospital Attikon, National and Kapodistrian University of Athens, 1, Rimini Str, Haidari, Athens Greece.
Ponikowski P; Department of Cardiology, University of Groningen, Hanzeplein 1, GZ, Groningen, the Netherlands.
Samani NJ; Department of Cardiology, University of Groningen, Hanzeplein 1, GZ, Groningen, the Netherlands.
van Veldhuisen DJ; Division of Molecular & Clinical Medicine, University of Dundee, Dundee, UK.
Zannad F; Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, Institute of Cardiology, University of Brescia, Piazza del Mercato, 15, Brescia, Italy.
Zwinderman AH; Department of Cardiovascular Sciences, University of Leicester, Glenfield Hospital, Groby Road, Leicester, UK.
Voors AA; NIHR Leicester Biomedical Research Centre, Glenfield Hospital, Groby Road, Leicester, UK.
van der Meer P; Department of Heart Diseases, Wroclaw Medical University, Rudolfa Weigla 5, Wroclaw, Poland.

Eur Heart J ; 39(48): 4269-4276, 2018 12 21.

Article de En | MEDLINE | ID: mdl-30551207

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Fragments peptidiques / Débit systolique / Marqueurs biologiques / Peptide natriurétique cérébral / Défaillance cardiaque Type d'étude: Guideline / Prognostic_studies Limites: Aged / Aged80 / Female / Humans / Male / Middle aged Langue: En Journal: Eur Heart J Année: 2018 Type de document: Article Pays d'affiliation: Pays-Bas Pays de publication: Royaume-Uni

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google